Docosahexaenoic acid (DHA) impairs hypoxia-induced cellular and exosomal overexpression of immune-checkpoints and immunomodulatory molecules in different subtypes of breast cancer cells.
Sepideh MaralbashiCynthia AslanHouman KahrobaMilad AsadiMohammad Sadegh Soltani-ZangbarNavideh HaghnavazFarhad JadidiFarhad SalariTohid KazemiPublished in: BMC nutrition (2024)
DHA supplementation may be utilized in breast cancer therapy for down-regulation of cellular and exosomal immune escape-related molecules.
Keyphrases